RIPK3 inhibitor prevents lung damage in severe influenza infection
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Drug discovery 2024-06, Vol.23 (6), p.417-417 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 417 |
|---|---|
| container_issue | 6 |
| container_start_page | 417 |
| container_title | Nature reviews. Drug discovery |
| container_volume | 23 |
| creator | Willson, Joseph |
| description | |
| doi_str_mv | 10.1038/d41573-024-00072-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3046512500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3064763029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-d5225f65f772af768481c282f581a4fd755ed6a4d79387a1b23a20ef691bf1233</originalsourceid><addsrcrecordid>eNp9kM1LwzAchoMobk7_AQ9S8OKlmu9kRx1-DAeK6DmkbTI72nQmrUP_ejM7J3jwlJf8nt-b8ABwjOA5gkReFBQxQVKIaQohFDhd7YAhooKmSEi6u82CD8BBCAsIEUcC74MBkZxJTsZDcPU0fbwnSeley6xsG58svXk3rg1J1bl5Uuhaz00cJyFe-3WyVWfcp14nk7dl4w7BntVVMEebcwRebq6fJ3fp7OF2OrmcpTnBvE0LhjGznFkhsLaCSypRjiW2TCJNbSEYMwXXtBBjIoVGGSYaQ2P5GGUWYUJG4KzvXfrmrTOhVXUZclNV2pmmC4pAyhnCDMKInv5BF03nXfxdpDgVnEA8jhTuqdw3IXhj1dKXtfYfCkG1Nqx6wyoaVt-G1SounWyqu6w2xXblR2kESA-EOHJz43_f_qf2C8mjhPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3064763029</pqid></control><display><type>article</type><title>RIPK3 inhibitor prevents lung damage in severe influenza infection</title><source>MEDLINE</source><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Willson, Joseph</creator><creatorcontrib>Willson, Joseph</creatorcontrib><identifier>ISSN: 1474-1776</identifier><identifier>ISSN: 1474-1784</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/d41573-024-00072-w</identifier><identifier>PMID: 38658639</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Biomedicine ; Biotechnology ; Cancer Research ; Humans ; Influenza, Human - drug therapy ; Influenza, Human - prevention & control ; Lung - drug effects ; Medicinal Chemistry ; Mice ; Molecular Medicine ; Pharmacology/Toxicology ; Protein Kinase Inhibitors - pharmacology ; Protein Kinase Inhibitors - therapeutic use ; Receptor-Interacting Protein Serine-Threonine Kinases - antagonists & inhibitors ; Receptor-Interacting Protein Serine-Threonine Kinases - metabolism ; Research Highlight</subject><ispartof>Nature reviews. Drug discovery, 2024-06, Vol.23 (6), p.417-417</ispartof><rights>Springer Nature Limited 2024</rights><rights>Springer Nature Limited 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-d5225f65f772af768481c282f581a4fd755ed6a4d79387a1b23a20ef691bf1233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/d41573-024-00072-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/d41573-024-00072-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38658639$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Willson, Joseph</creatorcontrib><title>RIPK3 inhibitor prevents lung damage in severe influenza infection</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><subject>Animals</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Cancer Research</subject><subject>Humans</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - prevention & control</subject><subject>Lung - drug effects</subject><subject>Medicinal Chemistry</subject><subject>Mice</subject><subject>Molecular Medicine</subject><subject>Pharmacology/Toxicology</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Receptor-Interacting Protein Serine-Threonine Kinases - antagonists & inhibitors</subject><subject>Receptor-Interacting Protein Serine-Threonine Kinases - metabolism</subject><subject>Research Highlight</subject><issn>1474-1776</issn><issn>1474-1784</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1LwzAchoMobk7_AQ9S8OKlmu9kRx1-DAeK6DmkbTI72nQmrUP_ejM7J3jwlJf8nt-b8ABwjOA5gkReFBQxQVKIaQohFDhd7YAhooKmSEi6u82CD8BBCAsIEUcC74MBkZxJTsZDcPU0fbwnSeley6xsG58svXk3rg1J1bl5Uuhaz00cJyFe-3WyVWfcp14nk7dl4w7BntVVMEebcwRebq6fJ3fp7OF2OrmcpTnBvE0LhjGznFkhsLaCSypRjiW2TCJNbSEYMwXXtBBjIoVGGSYaQ2P5GGUWYUJG4KzvXfrmrTOhVXUZclNV2pmmC4pAyhnCDMKInv5BF03nXfxdpDgVnEA8jhTuqdw3IXhj1dKXtfYfCkG1Nqx6wyoaVt-G1SounWyqu6w2xXblR2kESA-EOHJz43_f_qf2C8mjhPA</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Willson, Joseph</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20240601</creationdate><title>RIPK3 inhibitor prevents lung damage in severe influenza infection</title><author>Willson, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-d5225f65f772af768481c282f581a4fd755ed6a4d79387a1b23a20ef691bf1233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Cancer Research</topic><topic>Humans</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - prevention & control</topic><topic>Lung - drug effects</topic><topic>Medicinal Chemistry</topic><topic>Mice</topic><topic>Molecular Medicine</topic><topic>Pharmacology/Toxicology</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Receptor-Interacting Protein Serine-Threonine Kinases - antagonists & inhibitors</topic><topic>Receptor-Interacting Protein Serine-Threonine Kinases - metabolism</topic><topic>Research Highlight</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Willson, Joseph</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Willson, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RIPK3 inhibitor prevents lung damage in severe influenza infection</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>23</volume><issue>6</issue><spage>417</spage><epage>417</epage><pages>417-417</pages><issn>1474-1776</issn><issn>1474-1784</issn><eissn>1474-1784</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38658639</pmid><doi>10.1038/d41573-024-00072-w</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-1776 |
| ispartof | Nature reviews. Drug discovery, 2024-06, Vol.23 (6), p.417-417 |
| issn | 1474-1776 1474-1784 1474-1784 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3046512500 |
| source | MEDLINE; Nature; SpringerLink Journals - AutoHoldings |
| subjects | Animals Biomedicine Biotechnology Cancer Research Humans Influenza, Human - drug therapy Influenza, Human - prevention & control Lung - drug effects Medicinal Chemistry Mice Molecular Medicine Pharmacology/Toxicology Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Receptor-Interacting Protein Serine-Threonine Kinases - antagonists & inhibitors Receptor-Interacting Protein Serine-Threonine Kinases - metabolism Research Highlight |
| title | RIPK3 inhibitor prevents lung damage in severe influenza infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T01%3A58%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RIPK3%20inhibitor%20prevents%20lung%20damage%20in%20severe%20influenza%20infection&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Willson,%20Joseph&rft.date=2024-06-01&rft.volume=23&rft.issue=6&rft.spage=417&rft.epage=417&rft.pages=417-417&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/d41573-024-00072-w&rft_dat=%3Cproquest_cross%3E3064763029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3064763029&rft_id=info:pmid/38658639&rfr_iscdi=true |